The Hair Loss Encyclopedia
clinical trial evaluating baricitinib for severe alopecia areata
BRAVE-AA2 is a clinical trial designed to evaluate the efficacy and safety of a drug called baricitinib for treating alopecia areata, an autoimmune condition that causes hair loss. The trial specifically focuses on adults with severe alopecia areata and aims to determine how well the drug can help regrow hair and improve patients' quality of life.